Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative

Wild, Robert A.; Hovey, Kathleen M.; Andrews, Christopher; More

Menopause. 28(6):610-618, June 2021.

Menopausal status and observed differences in the gut microbiome in women with and without HIV infection

Peters, Brandilyn A.; Xue, Xiaonan; Wang, Zheng; More

Menopause. 28(5):491-501, May 2021.

Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA)

Santoro, Nanette; Waldbaum, Arthur; Lederman, Samuel; More

Menopause. 27(12):1350-1356, December 2020.

A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety

Gaspard, Ulysse; Taziaux, Mélanie; Mawet, Marie; More

Menopause. 27(8):848-857, August 2020.

Associations of social, physical, and financial factors with diet quality among older, community-dwelling women

Shikany, James M.; Manson, JoAnn E.; Shadyab, Aladdin H.; More

Menopause. 27(7):756-762, July 2020.

Incidence of diabetes according to metabolically healthy or unhealthy normal weight or overweight/obesity in postmenopausal women: the Women's Health Initiative

Cordola Hsu, Amber R.; Ames, Susan L.; Xie, Bin; More

Menopause. 27(6):640-647, June 2020.

A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause

Fraser, Graeme L.; Lederman, Samuel; Waldbaum, Arthur; More

Menopause. 27(4):382-392, April 2020.

Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial

El Khoudary, Samar R.; Venugopal, Vidya; Manson, JoAnn E.; More

Menopause. 27(3):255-262, March 2020.

Comparative effects of high-intensity interval training with combined training on physical function markers in obese postmenopausal women: a randomized controlled trial

Nunes, Paulo R. P.; Martins, Fernanda M.; Souza, Aletéia P.; More

Menopause. 26(11):1242-1249, November 2019.

Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy

Dorfman, Caroline S.; Arthur, Sarah S.; Kimmick, Gretchen G.; More

Menopause. 26(8):823-832, August 2019.

Sexual frequency and pain in a randomized clinical trial of vaginal estradiol tablets, moisturizer, and placebo in postmenopausal women

Mitchell, Caroline M.; Guthrie, Katherine A.; Larson, Joseph; More

Menopause. 26(8):816-822, August 2019.

Perceived social support and the risk of cardiovascular disease and all-cause mortality in the Women's Health Initiative Observational Study

Freeborne, Nancy; Simmens, Samuel J.; Manson, JoAnn E.; More

Menopause. 26(7):698-707, July 2019.

Early life exposure to famine and reproductive aging among Chinese women

Wang, Nengying; Huang, Yinqiong; Wen, Junping; More

Menopause. 26(5):463-468, May 2019.

Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease

Karim, Roksana; Koc, Melissa; Rettberg, Jamaica R.; More

Menopause. 26(1):7-15, January 2019.

The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women

Moral, Eloy; Delgado, Juan L.; Carmona, Francisco; More

Menopause. 25(12):1418-1423, December 2018.

Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study

Waetjen, L. Elaine; Crawford, Sybil L.; Chang, Po-Yin; More

Menopause. 25(10):1094-1104, October 2018.

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

Prague, Julia K.; Roberts, Rachel E.; Comninos, Alexander N.; More

Menopause. 25(8):862-869, August 2018.